Resources from the same session
Patient selection: Genomic matching to Phase I trials, NGS, ctDNA, existing programmes
Presenter: T.A. Yap, US
Session: Session 3 - Patient selection, response and toxicity assessment
Resources:
Slides
Webcast
Safety and adverse events management
Presenter: B. Tran, AU
Session: Session 3 - Patient selection, response and toxicity assessment
Resources:
Slides
Webcast
Assessing efficacy in novel Phase I trials
Presenter: T. Shimizu, JP
Session: Session 3 - Patient selection, response and toxicity assessment
Resources:
Slides
Webcast